ArticleFrontiers in oncology2026
Assessment of tissue homogenate levels of TGM1, PPL and KRT8 in a group of patients with HNSCC tumors and matched surgical margin samples.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies with significantly increasing incidence and mortality. Associated TGM1, PPL, and KRT proteins are involved in epithelial cell structure, adhesion, and differentiation. Objective patients and methods: This study aimed to evaluate TGM1, PPL, and KRT8 levels in tumors and matched surgical margin samples from 52 HNSCC patients and assess correlations with clinical and demographic variables using ELISA. Results: No significant differences in TGM1, PPL, and KRT8 levels were found between tumor and margin samples. However, in tumor tissue, TGM1 and KRT8 levels showed a statistically significant association with T status. In margins, PPL and KRT8 levels were also associated with T status. Additionally, PPL and TGM1 levels were correlated with N status in both tumor and margin samples, respectively. A significantly higher level of PPL was observed in OSCC tumors compared to HPSCC+LSCC. TGM1 levels in tumor and margin samples were correlated in patients with concomitant diseases. Analysis of HPV and p16 status revealed differences in PPL and KRT8 levels between tumor and margin samples. Furthermore, differences in PPL, TGM1, and KRT8 levels were observed in relation to smoking and alcohol use, distinguishing regular or occasional users from abstinent patients. Conclusions: Our results suggest that impaired TGM1, PPL, and KRT8 signaling pathways might play a role in HNSCC, indicating their potential relevance for future diagnostic and therapeutic investigations. Further studies are needed to confirm our findings, clarify the mechanistic role of these proteins in disease progression, and assess their clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.